<DOC>
	<DOCNO>NCT02335294</DOCNO>
	<brief_summary>The primary objective evaluate analgesic efficacy IV TRV130 compare placebo patient acute postoperative pain follow abdominoplasty .</brief_summary>
	<brief_title>A Study TRV130 Treatment Pain After Abdominoplasty</brief_title>
	<detailed_description>The primary objective evaluate analgesic efficacy intravenous ( IV ) TRV130 administer via patient control analgesia device ( PCA ) compare placebo administer via PCA patient moderate severe , acute postoperative pain follow abdominoplasty .</detailed_description>
	<mesh_term>Morphine</mesh_term>
	<criteria>&gt; =18 &lt; =65 year age . Plans undergo abdominoplasty procedure additional collateral procedure . Is able understand comply procedure study requirement , provide write informed consent study procedure . ASA Physical Status Classification System classification P3 worse . Has surgical postsurgical complication . Has clinically significant medical condition history condition may interfere interpretation efficacy , safety , tolerability data obtain trial , may interfere absorption , distribution , metabolism , excretion drug . Has previously participate another TRV130 clinical study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Pain</keyword>
	<keyword>abdominoplasty</keyword>
	<keyword>PCA</keyword>
</DOC>